Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface

Experimental Neurology

Volumn 143, Issue 1, 1997, Pages 61-69

  Zimmer, C ^a   Wright Jr , S C ^a   Engelhardt, R T ^b   Johnson, G A ^b   Kramm, Christoff ^a   Breakefield, X O ^a   Weissleder, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOCYTOSIS; GLIOMA; HISTOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

EID: 0031027059     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6350     Document Type: Article

References (35)

1. 1. BJERKNES, R., R. BJERKVIG, AND O. LAERUM. 1987. Phagocytic capacity of normal and malignant rat glial cells in culture. J. Natl. Cancer Inst. 78: 279-288.
2. 2. NOSKE, W., H. LENTZEN, K. LANGE, AND K. KELLER. 1982. Phagocytotic activity of glial cells in culture. Exp. Cell Res. 142: 437-445.
3. 3. BEAMAN, L., AND B. BEAMAN. 1994. Differences in the interactions of nocardia asteroides with macrophage, endothelial and astrocytoma cell lines. Infect. Immun. 62: 1787-1798.
4. 4. YOUNESS, E., B. BARLOGIE, M. AHEARN, AND J. TRUJILLO. 1980. Tumor cell phagocytosis. Arch. Pathol. Lab. Med. 104: 651-653.
5. 5. MARIN-PADILLA, M. 1977. Erythrophagocytosis by epithelial cells of a breast carcinoma. Cancer 39: 1085-1089.
6. 6. NATELSON, E., E. LYNCH, R. HETTIG, AND C. ALFREY. 1968. Histiocytic medullary reticulosis. Arch. Intern. Med. 122: 223-229.
7. 7. VAN PETEGHEM, M. M. MAREEL, AND G. DE BRUYNE. 1980. Phagocytic capacity of invasive malignant cells in three-dimensional culture. Virchows Arch. B Cell Pathol. 34: 193-204.
8. 8. BUYS, S., AND J. KAPLAN. 1987. Effect of phagocytosis on receptor distribution and endocytic activity in macrophages. J. Cell. Physiol. 131: 442-449.
9. 9. BERLIN, R., J. OLIVER, AND R. WALTER. 1978. Surface functions during mitosis I: Phagocytosis, pinocytosis and mobility of surface-bound Con A. Cell 15: 327-341.
10. 10. MOHLER, J., AND Y. SHARIEF. 1993. Flow cytometric assay of pinocytosis: Correlation with membrane ruffling and metastatic potential in the Dunning R-3327 rat prostatic adenocarcinoma model. Cytometry 14: 826-831.
11. 11. SWANSON, J., E. BURKE, AND S. SILVERSTEIN. 1987. Tubular lysosomes accompany stimulated pinocytosis in macrophages. J. Cell Biol. 104: 1217-1222.
12. 12. SWANSON, J., A. LOCKE, P. ANSEL, AND P. HOLLENBECK. 1992. Radial movement of lysosomes along microtubules in permeabilized macrophages. J. Cell Sci. 103: 201-209.
13. 13. WEISSLEDER, R., A. BOGDANOV, AND M. PAPISOV. 1995. Long-circulating iron oxides for MR imaging. Pages 321-334 in V. Torchilin, Ed., Advanced Drug Delivery Reviews. CRC Press, Boca Raton, FL.
14. 14. BOGDANOV, A., R. WEISSLEDER, AND T. BRADY. 1995. Long-circulating blood pool imaging agents. Pages 335-348 in V. Torchilin, Ed., Advanced Drug Delivery Reviews. CRC Press, Boca Raton, FL.
15. 15. ZIMMER, C., R. WEISSLEDER, K. POSS, A. BOGDANOVA, S. WRIGHT, AND W. ENOCHS. 1995. MR imaging of phagocytosis in experimental gliomas. Radiology 197: 533-538.
16. 16. PRATTEN, M., AND J. LLOYD. 1986. Pinocytosis and phagocytosis: The effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim. Biophys. Acta 881: 307-313.
17. 17. SCHULZE, E., K. POSS, A. BOGDANOVA, N. NOSSIV, AND R. WEISSLEDER. 1994. Determinants of intracellular uptake of iron oxide contrast agents. 80th Scientific Assembly and Annual Meeting of the RSNA, Chicago.
18. 18. WEISZSAECKER, M., D. F. DEEN, M. L. ROSENBLUM, T. HOSHINO, P. H. GUTIN, AND M. BARKER. 1981. The 9L rat brain tumor: Description and application of an animal model. J. Neurol. 224: 183-192.
19. 19. EZZEDINE, Z., R. MARTUZA, D. PLATIKA, ET AL. 1991. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3: 608-614.
20. 20. SCHARF, J. M., E. J. BOVIATSIS, C. FLEET, X. O. BREAKEFIELD, AND E. A. CHIOCCA. 1994. Genetically modified rat 9L gliosarcoma cells facilitate detection of infiltrating tumor cells in a rat model of brain neoplasms. Transgenics 1: 219-224.
21. 21. SHEN, T., R. WEISSLEDER, M. PAPISOV, A. BOGDANOV, AND T. BRADY. 1993. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties. Magn. Reson. Med. 29: 599-604.
22. 22. CHUNG, C., R. WEISSLEDER, L. JOSEPHSON, H. BENGELE, AND T. BRADY. 1996. Physical properties of MION-46 and AMI-227. Society of Magnetic Resonance, 4th Scientific Meeting, New York.
23. 23. JOHNSON, G. A., H. BENVENISTE, R. D. BLACK, L. W. HEDLUND, R. R. MARONPOT, AND B. R. SMITH. 1993. Histology by magnetic resonance microscopy. Magn. Reson. Q. 9: 1-30.
24. 24. KOEPPEN, A., AND R. BORKE. 1991. Experimental superficial siderosis of the central nervous system. 1. Morphological observations. J. Neuropathol. Exp. Neurol. 50: 579-594.
25. 25. JAIN, R. 1990. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9: 253-266.
26. 27. DVORAK, H., J. NAGY, J. DVORAK, AND A. DVORAK. 1988. Identification and characterization of blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133: 95-109.
27. 27. PLATE, K., G. BREIER, AND W. RISAU. 1994. Molecular mechanism and developmental and tumor angiogenesis. Brain Pathol. 4: 207-218.
28. 28. NISHIO, S., M. OHTA, M. ABE, AND K. KITAMURA. 1983. Microvascular abnormalities in ethylnitrourea (ENU) induced rat brain tumors: Structural basis for altered blood brain barrier function. Acta Neuropathol. 59: 1-10.
29. 29. BOUCHER, Y., AND R. JAIN. 1992. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: Implications for vascular collapse. Cancer Res. 52: 5110-5114.
30. 30. O'CONNOR, S., AND W. BALE. 1984. Accessability of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res. 44: 3719-3723.
31. 31. BOGDANOVA, A., A. BOGDANOV, AND R. WEISSLEDER. 1996. Uptake of dextran coated particles in endocytotically active cells is mediated by different mechanism. In preparation.
32. 32. WEISSLEDER, R., D. STARK, B. ENGELSTAD, ET AL. 1989. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am. J. Roentgenol. 152: 167-173.
33. 33. SCHENCK, J., F. JOLESZ, P. ROEMER, ET AL. 1995. Superconducting open-configuration MR imaging system for image-guided therapy. Radiology 195: 805-814.
34. 34. SCHREIBER, G., K. HELLSTRÖM, AND I. HELLSTRÖM. 1992. An unmodified anticarcinoma antibody, BR96, localizes to and inhibits the outgrowth of human tumors in nude mice. Cancer Res. 52: 3262-3266.
35. 35. TRAIL, P., D. WILLNER, S. LASCH, ET AL. 1993. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 261: 212-215.